111 (YI) Stock Price, News & Analysis

Company Overview

111, Inc. (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc. aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc.’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods. The platform offers specialized services for prescription fulfillment, enabling users to upload medical prescriptions securely and receive licensed medications through certified pharmacy partners. In addition to its core pharmaceutical offerings, the company features a curated selection of imported wellness and beauty brands sourced from markets such as the United States, Europe, and Japan.

With a focus on cross-border e-commerce, 111, Inc. partners with domestic manufacturers and international suppliers to ensure product authenticity and quality control. The company operates strategically located warehouses to facilitate efficient order processing and delivery, leveraging both direct shipping from overseas distributors and local inventory hubs. Its digital infrastructure supports real-time inventory tracking, customer support, and data-driven recommendations to enhance the consumer experience.

Founded in 2010 and headquartered in Shanghai, 111, Inc. has grown alongside China’s expanding digital healthcare market. Its management team brings together expertise in online retail, supply chain logistics, and regulatory compliance to navigate the complexities of pharmaceutical distribution. Through ongoing platform enhancements and strategic partnerships, 111, Inc. continues to expand its reach and service offerings in China’s rapidly evolving healthcare e-commerce landscape.

Key Stats

• Today's Range: $5.79 to $6.17
• 50-Day Range: $5.58 to $7.68
• 52-Week Range: $2.48 to $11.17
• Volume: 26,608 shs
• Average Volume: 12,926 shs
• Market Capitalization: $52.70 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

111 Stock Analysis - MarketRank™

111 scored higher than 18% of companies evaluated by MarketBeat, and ranked 810th out of 864 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

111 has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

111 has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of 111 is -6.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of 111 is -6.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.28% of the float of 111 has been sold short.

Short Interest Ratio / Days to Cover

111 has a short interest ratio ("days to cover") of 1.18, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in 111 has recently decreased by 45.06%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

111 does not currently pay a dividend.

Dividend Growth

111 does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.44

News Sentiment

111 has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for 111 this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, 111 insiders have not sold or bought any company stock.

Percentage Held by Insiders

43.90% of the stock of 111 is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

21.32% of the stock of 111 is held by institutions.

Company Calendar

• Last Earnings: 9/17/2025
• Today: 5/14/2026
• Next Earnings (Estimated): 5/21/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Retail
• Current Symbol: NASDAQ:YI
• CIK: 1738906
• Web: www.111.com.cn
• Phone: 862120536666
• Fax: N/A
• Employees: 1,238
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($1.00)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.65 million
• Net Margins: -0.53%
• Pretax Margin: -0.18%
• Return on Equity: N/A
• Return on Assets: -2.72%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.09
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: $1.80 billion
• Price / Sales: 0.03
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($11.94) per share
• Price / Book: -0.51

Miscellaneous

• Outstanding Shares: 8,640,000
• Free Float: 4,849,000
• Market Cap: $52.70 million
• Optionable: Optionable
• Beta: 0.66